It is possible that the loss of PPARG expression or activity through any of these epigenetic or genetic mechanisms could result in a self-sustaining negative feedback cycle whereby the initial loss of PPARγ anti-inflammatory activity results in increased inflammatory cytokine production that results in a further degradation of PPARγ signaling within the tumor cells themselves or surrounding stromal cells. The gene discussed is PPARG; the disease is neoplasm.